Vireo Growth (VREOF) Cash & Current Investments (2020 - 2026)

Vireo Growth (VREOF) reported Cash & Current Investments of $153.2 million for Q1 2026, up 74.19% on a YoY basis from $88.0 million in Q1 2025, and up 7.28% sequentially from $142.8 million in Q4 2025.

Vireo Growth (VREOF) Cash & Current Investments (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Cash & Current Investments data on file, last reported at $153.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 74.19% year-over-year to $153.2 million; the trailing twelve-month figure through Mar 2026 stood at $153.2 million (up 74.19% YoY), and the FY2025 full-year result was $142.8 million, up 52.12% from the prior year.
  • Cash & Current Investments advanced to $153.2 million in Q1 2026, from $142.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $153.2 million in Q1 2026 to a low of $7.3 million in Q3 2024.
  • A 5-year average of $49.6 million and a median of $17.0 million in 2022 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments tumbled 78.79% in 2022 and jumped 1528.49% in 2025, its largest moves.
  • Tracing VREOF's Cash & Current Investments over 5 years: stood at $15.1 million in 2022, then increased by 18.17% to $17.9 million in 2023, then soared by 424.36% to $93.9 million in 2024, then jumped by 52.12% to $142.8 million in 2025, then grew by 7.28% to $153.2 million in 2026.
  • Business Quant data shows VREOF's Cash & Current Investments at $153.2 million in Q1 2026, $142.8 million in Q4 2025, and $118.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.49 Bn 30.55 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.13 Bn 20.97 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn 428.00 Mn
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn 153.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 153.20 Mn
Dec 31, 2025 142.80 Mn
Sep 30, 2025 118.55 Mn
Jun 30, 2025 100.41 Mn
Mar 31, 2025 87.95 Mn
Dec 31, 2024 93.87 Mn
Sep 30, 2024 7.28 Mn
Jun 30, 2024 11.23 Mn
Mar 31, 2024 12.60 Mn
Dec 31, 2023 17.90 Mn
Sep 30, 2023 13.30 Mn
Jun 30, 2023 11.35 Mn
Mar 31, 2023 10.35 Mn
Dec 31, 2022 15.15 Mn
Sep 30, 2022 21.84 Mn
Jun 30, 2022 16.97 Mn
Mar 31, 2022 8.60 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 11.78 Mn
Jun 30, 2021 20.83 Mn